Craft
  • Home
  •  / PetMed Express
PetMed Express

PetMed Express

Average Spending per Transaction

$85

Q2, 2018

Revenue

$273.4 M

FY, 2022

Market Capitalization

$403.2 M

2022-11-18

PetMed Express Summary

Company summary

Overview
PetMed Express markets prescription and non-prescription pet medications, and other health products for dogs and cats, direct to the consumer. The Company's products include brands of medication, such as Frontline Plus, K9 Advantix II, Advantage II, Heartgard Plus, Sentinel, Revolution and Rimadyl. PetMed also offers additional pet supplies for sale on its Website, which are drop shipped to its customers by third parties.
Type
Public
Status
Active
Founded
1996
HQ
Delray Beach, FL, US | view all locations
Website
http://www.1800petmeds.com/
Cybersecurity rating
ESG rating
40-49 out of 100|View all ESG data
Sectors

Operating MetricsView all

Stock Keeping Units

3K

FY, 2017

Visitors

32M
3.0%

FY, 2017

Average Spending per Transaction

$85
3.7%

Q2, 2018

LocationsView all

1 location detected

  • Delray Beach, FL HQ

    United States

    420 S Congress Ave #100Delray

PetMed Express Financials

Summary financials

Revenue (Q2, 2023)
$65.4M
Gross profit (Q2, 2023)
$18.5M
Net income (Q2, 2023)
$2.6M
Cash (Q2, 2023)
$96.5M
EBIT (Q2, 2023)
$3.0M

Footer menu